Demand for Instem’s SEND
platform is soaring

A global provider of leading software solutions
and services to the life sciences community.

Helping our clients bring life enhancing products to market faster.

Learn more

Creating a more connected ecosystem in the
life sciences industry by consolidating and
harmonizing a fragmented IT marketplace.

Learn more

Welcome to the Instem Investor Centre

Instem (AIM:INS.L) is a leading provider of IT solutions and services to the global early development healthcare market, delivering compelling solutions for data collection, analysis and regulatory submissions management.


Latest News

03 June 2019 - Director/PDMR Shareholding

Read More

31 May 2019 - Notification of Major Holdings

Read More

24 May 2019 - Director/PDMR Shareholding

Read More

Annual Report 2017

Strong margins and cash performance

Annual Report 2017

We have maintained our pre-eminent position in the preclinical market and taken further market share in the now FDA mandated SEND market.

Another year of solid delivery

Research Note by Gareth Evans of Progressive Equity Research